Enhanced binding of the N501Y‐mutated SARS‐CoV‐2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations

Recently, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants (B.1.1.7 and B.1351) have emerged harbouring mutations that make them highly contagious. The N501Y mutation within the receptor‐binding domain (RBD) of the spike protein of these SARS‐CoV‐2 variants may enhance binding t...

Full description

Saved in:
Bibliographic Details
Published inFEBS letters Vol. 595; no. 10; pp. 1454 - 1461
Main Authors Luan, Binquan, Wang, Haoran, Huynh, Tien
Format Journal Article
LanguageEnglish
Published England John Wiley and Sons Inc 01.05.2021
Subjects
ACE2
antibody
N501Y
Research Letter
SARS‐CoV‐2
spike protein
ACE2
N501Y
SARS-CoV-2
antibody
spike protein
Online AccessGet full text

Cover

More Information
Summary:Recently, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants (B.1.1.7 and B.1351) have emerged harbouring mutations that make them highly contagious. The N501Y mutation within the receptor‐binding domain (RBD) of the spike protein of these SARS‐CoV‐2 variants may enhance binding to the human angiotensin‐converting enzyme 2 (hACE2). However, no molecular explanation for such an enhanced affinity has so far been provided. Here, using all‐atom molecular dynamics simulations, we show that Y501 in the mutated RBD can be well‐coordinated by Y41 and K353 in hACE2 through hydrophobic interactions, which may increase the overall binding affinity of the RBD for hACE2 by approximately 0.81 kcal·mol−1. The binding dynamics revealed in our study may provide a working model to facilitate the design of more effective antibodies.
Bibliography:Edited by Michael Bubb
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0014-5793
1873-3468
DOI:10.1002/1873-3468.14076